- The Ministry of Health (MoH) has warned that health workers are at high risk of contracting Mpox due to their close contact with infected people
- People who have close contact with confirmed Mpox patients are also identified as high risk by the MoH
- Kenyans with multiple partners are at risk of getting Mpox, according to the latest advice from the ministry
- The warning is part of the Ministry of Health's efforts to increase awareness and prevent the spread of Mpox, emphasizing the need for caution
Nairobi – The Ministry of Health (MoH) has warned to identify groups of people who are at high risk of contracting the Mpox disease.
Source: Facebook
Who is at risk of contracting Mpox?
In its latest advisory, the Ministry of Health indicated that health workers and individuals who are close to confirmed Mpox patients are at high risk of infection.
Kenyans with multiple partners are also at risk of infection, with the ministry stressing the need for caution and preventive measures.
“Health care workers, people close to confirmed cases, and those with multiple sexual partners have a higher chance of infection,” MoH warned in his warning.
The Ministry of Health's alert is part of ongoing efforts to raise awareness and prevent the spread of Mpox, which continues to grow as a public health issue.
Symptoms and how to prevent the disease
Previously, the Ministry of Health explained in detail the symptoms of the disease, noting that an infected person may show symptoms such as skin rash or mucosal lesions, fever, headache, general pain, and swollen lymph nodes.
However, individuals can avoid contracting the disease by avoiding close contact with those showing symptoms of Mpox or confirmed cases.
One can also ensure their safety by washing hands regularly with soap and water or using hand sanitizers.
It is important to seek treatment immediately if any symptoms occur and to self-isolate to prevent the virus from spreading.
Mpox vaccine maker speaks out
Earlier, the Danish pharmaceutical manufacturer Bavarian Nordic said “well prepared” to offer its Mpox vaccine for the current outbreak of the virus than for the 2022 pandemic.
The vaccine maker said last week it was ready to produce up to 10 million doses of its Mpox vaccine by the end of 2025, up from 500,000 doses now.
According to the company, the level of fear is not as high as in 2022-2023.
Speaking at his quarterly earnings presentation, CEO Paul Chaplin said, “We are well prepared”.
READ ENGLISH VERSION
Do you have an exciting story that you would like us to publish? Please contact us via news@tuko.co.ke or WhatsApp: 0732482690.
Source: TUKO.co.ke
